Long-term Benefits of CPAP or MAD Treatment on the Sleep of OSAS Patients
The REMAP study aims to understand the long-term effects of treatments like CPAP and MAD on people with obstructive sleep apnoea (OSA). Researchers will follow 400 patients in France for a year, carefully checking their sleep patterns using home sleep devices. They'll also ask patients about their sleep quality and overall quality of life. The main goal is to see how these treatments change sleep over time and identify what factors help predict who will get the most benefit. This information will help doctors better tailor treatments for people living with OSA, ensuring they get the most effective care for a better night's sleep.
At a glance
What is this study about?
This study, called REMAP, wants to find out more about how two common treatments for sleep apnoea – CPAP and MAD – affect people over a longer period. Sleep apnoea is a condition where your breathing repeatedly stops and starts during sleep. This can lead to poor sleep quality and impact your health.
Researchers will follow about 400 patients with sleep apnoea in France for one year. They will use special devices that patients wear at home to measure their sleep in detail. They'll be looking at things like how quickly people fall asleep, how much deep sleep they get, and overall sleep quality. Patients will also be asked about how they feel and their quality of life.
By collecting all this information, the study hopes to better understand how CPAP and MAD treatments change sleep patterns and improve daily life for people with sleep apnoea. It will also try to figure out if there are certain things that predict who will respond best to which treatment. This knowledge could help doctors make more informed decisions about treatment plans for future patients, leading to better sleep and overall health.
Key takeaways
- The study looks at CPAP and MAD treatments for sleep apnoea.
- It follows patients for one year to see long-term effects.
- Sleep is measured using home devices, and patients report on their quality of life.
- The goal is to understand who benefits most from which treatment.
- It's an observational study, so you won't get a new treatment.
Who may be eligible?
To join this study, you must be between 18 and 80 years old, male or female. You need to have been diagnosed with obstructive sleep apnoea (OSA) and your doctor must have decided that CPAP or MAD treatment is suitable for you. You also need to have had a specific sleep test using a device called 'Sunrise', or have been part of a previous study called SunSAS.
There are some reasons why you wouldn't be able to join. For example, if you've already been treated for sleep apnoea with CPAP or MAD in the last five years, or have certain other breathing problems like COPD. If you have severe heart problems or conditions that make CPAP or MAD unsuitable for you, you also wouldn't be able to take part. Finally, you need to be able to complete the full year of the study.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you between 18 and 80 years old?
- Do you have obstructive sleep apnoea (OSA)?
- Has your doctor said you're suitable for CPAP or MAD treatment?
- Have you had a sleep test using a 'Sunrise' device?
- Have you NOT been treated with CPAP or MAD in the last five years?
- Do you NOT have severe heart conditions or other serious breathing problems?
What does participation involve?
The detailed information about what taking part involves is not fully provided here. However, based on the summary, if you join this study, you would be followed for one year. You would use a special home sleep device to monitor your sleep patterns. You would also be asked to share information about your sleep quality and overall quality of life. This likely involves completing questionnaires or surveys. Since the study aims to follow patients receiving CPAP or MAD, you would already be using one of these treatments as part of your usual care.
Potential risks and benefits
Locations (9)
- CHU AngersVerified postcodeAngers, France· Recruiting
- Centre Hospitalier Universitaire Grenoble AlpesVerified postcodeGrenoble, France· Recruiting
- CHU Lyon - Hôpital de la Croix-RousseVerified postcodeLyon, France· Recruiting
- Hopital Europeen MarseilleVerified postcodeMarseille, France· Recruiting
- APHP - Pitié-Salpêtrière University HospitalVerified postcodeParis, France· Recruiting
- AP-HP BichatVerified postcodeParis, France· Not yet recruiting
- CHU ReimsVerified postcodeReims, France· Recruiting
- Polyclinique St LaurentVerified postcodeRennes, France· Recruiting
- Centre du SommeilVerified postcodeSaint-Martin-d'Hères, France· Recruiting
Common questions
What is CPAP and MAD?
CPAP (Continuous Positive Airway Pressure) is a machine that helps keep your airway open while you sleep. MAD (Mandibular Advancement Device) is a custom-fit mouthguard that moves your jaw slightly forward to prevent your tongue and throat from blocking the airway.
What is sleep apnoea?
Sleep apnoea is a common condition where your breathing repeatedly stops and starts while you sleep, usually due to your airway temporarily closing. This can interrupt your sleep and make you feel tired during the day.
What kind of sleep test will be used?
The study mentions using a 'sleep connected at home' device, specifically from the 'Sunrise' company. This suggests a portable device you wear at home to record your sleep patterns.
Will I get a new treatment in this study?
No, this study is observing how existing treatments (CPAP or MAD) work over time. You will already be receiving one of these treatments as part of your standard care for sleep apnoea.
How long will I be involved if I join?
The study aims to follow patients for one year.
How to find out more
Elodie Aversenq
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.